PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.48%
Negative revenue growth while Healthcare median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-7.46%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-24.95%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-28.32%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
-25.47%
Negative net income growth while Healthcare median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-25.47%
Negative EPS growth while Healthcare median is 0.00%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-25.47%
Negative diluted EPS growth while Healthcare median is 0.00%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
-0.00%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
56.07%
10Y CAGR of 56.07% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
64.73%
5Y CAGR of 64.73% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
32.48%
3Y CAGR of 32.48% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
-100.00%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
126.36%
Net income/share CAGR of 126.36% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
101.74%
Net income/share CAGR of 101.74% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
77.60%
3Y net income/share CAGR of 77.60% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
195.62%
Equity/share CAGR of 195.62% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
123.30%
5Y equity/share CAGR of 123.30% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
57.64%
3Y equity/share CAGR of 57.64% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
No Data
No Data available this quarter, please select a different quarter.
266.67%
5Y dividend/share CAGR of 266.67% while Healthcare is zero. Walter Schloss sees at least some improvement that could compound over time.
144.44%
3Y dividend/share CAGR of 144.44% while Healthcare is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
-3.70%
AR shrinking while Healthcare median grows. Seth Klarman sees potential advantage unless it signals declining demand.
5.46%
Inventory growth of 5.46% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
-0.01%
Assets shrink while Healthcare median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
3.68%
BV/share growth of 3.68% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-5.56%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
0.60%
SG&A growth of 0.60% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.